| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1054.45 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 1078.86 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 979.611 | 95 |
| GSM780719 | Untreated after 4 days (C1_2) | 1069.99 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 1095.34 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1038.04 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 997.104 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1150.67 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1078.86 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1017.27 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1270.74 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1174.47 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1209.56 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1103.58 | 96 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1160.55 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1146.85 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1062.52 | 96 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1125.65 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1273.23 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1100.5 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1138.5 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1233.71 | 96 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1210.51 | 96 |